Navigation Links
NFL Docs Urge More Caution With Key Pain Med
Date:9/11/2012

TUESDAY, Sept. 11 (HealthDay News) -- New recommendations by NFL team doctors suggest increased caution in the use of the pain reliever ketorolac tromethamine (Toradol) by professional football players.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID). Athletes have long taken NSAIDs for pain prevention and relief before, during and after competition. But the recommendations by a task force developed through the NFL Team Physicians Society suggests more careful use of ketorolac.

The recommendations are published in the September/October issue of the journal Sports Health: A Multidisciplinary Approach.

"Ketorolac has been used most frequently as an analgesic pain reliever following strains, sprains and overuse injuries. Our recommendations on its use in NFL players hopefully will help minimize the risk of complications and allow for all parties involved in the health of athletes to better understand, how, when and why to use ketorolac more effectively and safely," lead author Dr. Matthew Matava, president-elect of the NFL Team Physicians Society, said in a journal news release.

The recommendations on ketorolac indicate:

  • It should be given only under the direct supervision and order of a team physician.
  • It should not be used before competition as a means of reducing anticipated pain.
  • It should only be used in players diagnosed with an injury or condition who are listed on the teams' latest injury report.
  • It should be given in the lowest effective therapeutic dose and for no more than five days.
  • It should be given by mouth under typical circumstances.
  • It should not be given by intramuscular and intravenous injection except following an acute, game-related injury where significant bleeding is not expected.
  • It should not be taken concurrently with other NSAIDs.

More information

The U.S. Food and Drug Administration offers a guide to the safe use of pain medicine.

-- Robert Preidt

SOURCE: Sports Health: A Multidisciplinary Approach, news release, Aug. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Precautions for tick-borne disease extend beyond Lyme
2. Use Caution When Exercising in Hot Weather
3. Supplements and cancer prevention: A cautionary tale
4. Penn study cautions use of drugs to block niacin flush
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NFL Docs Urge More Caution With Key Pain Med
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology: